Tilt Biotherapeutics raised €10M in a funding round in Jun 2022. The company is based in Helsinki, Finland. Investors in the round: Lifeline Ventures, Tesi. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
